Endometrial Scratching Prior to Controlled Ovarian Stimulation (COH) in Women Undergoing In-vitro Fertilization With Previous IVF Failure (ESICOHF)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified November 2010 by Mansoura University.
Recruitment status was  Not yet recruiting
Sponsor:
Information provided by:
Mansoura University
ClinicalTrials.gov Identifier:
NCT01245309
First received: November 19, 2010
Last updated: NA
Last verified: November 2010
History: No changes posted
  Purpose

Scratching the linning of the womb before IVF cycle could increase the chances of having a baby after an IVF cycle.


Condition Intervention Phase
Implantation Failure After Ivf
Procedure: scratching
Procedure: A PLACEBO PROCEDURE
Phase 0

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Endometrial Injury Prior to Controlled Ovarian Stimulation (COH) in Women Undergoing In-vitro Fertilization in Women With Previous IVF Failure.

Further study details as provided by Mansoura University:

Primary Outcome Measures:
  • live birth rate per woman [ Time Frame: 9 months ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • ongoing pregnancy rate [ Time Frame: 12 weeks ] [ Designated as safety issue: No ]

Estimated Enrollment: 500
Study Start Date: December 2010
Estimated Study Completion Date: March 2013
Estimated Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: scratching
endometrial scratching prior ivf cycle
Procedure: scratching
endometrial scratching before COH in IVF
Procedure: A PLACEBO PROCEDURE
A PLACEBO PROCEDURE
Placebo Comparator: PLACEBO
PLACEBO PROCEDURE
Procedure: A PLACEBO PROCEDURE
A PLACEBO PROCEDURE

  Eligibility

Ages Eligible for Study:   up to 40 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

WOMEN WITH PREVIOUS IVF FAILURE UNDERGOING IVF TREATMENT

-

Exclusion Criteria:

  • WOMEN>40 YEARS OLD WOMEN UNDERGOING THEIR FIRST IVF TREATMENT CYCLE
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01245309

Contacts
Contact: AHMED GIBREEL, MD 0020104045733 ahmedfathgi@yahoo.com

Locations
Egypt
Mansoura University Not yet recruiting
Mansoura, Egypt, 53111
Contact: Ahmed Gibreel     0020104045733     ahmedfathgi@yahoo.com    
Principal Investigator: Ahmed Gibree, MD            
Sponsors and Collaborators
Mansoura University
  More Information

No publications provided

Responsible Party: Dr Ahmed Gibreel, Mansoura University
ClinicalTrials.gov Identifier: NCT01245309     History of Changes
Other Study ID Numbers: AG1001
Study First Received: November 19, 2010
Last Updated: November 19, 2010
Health Authority: Egypt: Institutional Review Board

Additional relevant MeSH terms:
Adenoma
Neoplasms, Glandular and Epithelial
Neoplasms by Histologic Type
Neoplasms

ClinicalTrials.gov processed this record on June 13, 2013